微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 2.17% | -73.86% | 20.56% | 80/132 | 0.36% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 1.8% | -70.39% | 386.49% | 69/132 | 1.85% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.37% | -85.49% | -96.58% | 93/132 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 10.81% | 22.15% | 30.24% | 24/132 | 3.1% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 8.3% | -28.51% | 36.51% | 30/132 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 6.08% | 18.29% | 138.43% | 25/132 | 3.08% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 2.55% | -22.96% | -71.19% | 39/132 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 8.85% | -81.83% | -23.77% | 43/132 | 5.12% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 11.61% | -74.65% | 125.88% | 14/132 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 5.14% | -84.53% | 55.29% | 44/132 | 3.81% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 3.31% | -88.45% | -93.21% | 37/132 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 48.72% | 218.64% | 6.38% | 6/132 | 13.36% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 45.8% | 220.95% | 37.83% | 6/132 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 33.23% | 268% | 15.95% | 7/132 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 28.66% | 548.42% | 87.44% | 4/132 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 15.29% | -44.92% | 7.15% | 53/132 | 17.4% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 14.27% | 2% | 58.03% | 41/132 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 9.03% | -34.66% | 104.3% | 47/132 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 4.42% | 2% | -84.08% | 35/132 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 27.76% | 21.7% | 100.87% | 32/132 | 25.69% | 中红医疗 | 168% | 行业排名> |
| 2020-06-30 | 13.82% | 2% | -39.41% | 32/132 | 15.16% | 圣湘生物 | 112.46% | 行业排名> |
| 2019-12-31 | 22.81% | 118.7% | 118.7% | 28/132 | 14.38% | 博拓生物 | 108.13% | 行业排名> |
| 2018-12-31 | 10.43% | 1729.83% | 1729.83% | 68/132 | 12.98% | 圣湘生物 | 29.33% | 行业排名> |
| 2017-12-31 | 0.57% | 2% | 2% | 92/132 | 13.82% | 健尔康 | 84.09% | 行业排名> |